Related Experiment Video
Updated: Nov 18, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection
Rizwan Muhammad1, Richard Ogunti1, Basharat Ahmad1
1Howard University College of Medicine, 2041 Georgia Ave, NW, Washington, DC, 20060, USA.
Insights
Predictors of early mortality in minority patients with COVID-19 include advanced age and elevated biomarkers for inflammation, coagulation, and organ damage. These factors independently increase the risk of in-hospital death.
Area of Science:
- Medical Research
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) disproportionately affected minority populations.
- Understanding early mortality predictors is crucial for targeted interventions.
Purpose of the Study:
- To identify early mortality predictors in minority patients hospitalized with COVID-19.
- To inform clinical management and improve outcomes for high-risk individuals.
Main Methods:
- Retrospective analysis of 200 consecutively hospitalized COVID-19 patients.
- Collection of demographics, clinical characteristics, laboratory data, and mortality outcomes.
- Statistical analysis to identify independent predictors of in-hospital mortality.
Main Results:
- The study identified several key predictors of mortality.
- Advanced age (≥65 years) and elevated biomarkers (lactate dehydrogenase, C-reactive protein, ferritin, creatinine kinase, procalcitonin, D-dimer, creatinine) were independently associated with increased mortality risk.
- Non-survivors were significantly older with elevated markers of inflammation, coagulation, and acute organ damage.
Conclusions:
- Patients of advanced age presenting with elevated biomarkers of inflammation, coagulation, and end-organ damage face a higher risk of mortality from COVID-19.
- These findings highlight the importance of monitoring specific biomarkers for early risk stratification and timely intervention.
Objectives:
To identify the early mortality predictors in minority patients hospitalized with coronavirus disease 2019 (COVID-19).
Design:
Demographics, presenting characteristics, admission laboratory data, ICU admission, and mortality data were collected from 200 consecutively hospitalized patients with COVID-19.
Results:
The mean (SD) age was 58.9 (15.1) years, 121(60.5%) were men, 143 (71.5%) were African Americans, and 33 (16.5%) were Latino. Common presenting symptoms were cough 130 (65.0%), shortness of breath 129 (64.5%), and fever 121 (60.5%). One or more comorbid illness occurred in 171 (85.5%) and common comorbidities were hypertension (130 (65.2%)), diabetes (100 (50.0%)) and chronic kidney disease (60 (30.0%)). Of the 200 patients, 71 (35.5%) were treated in the ICU, 47 (24.2%) received mechanical ventilation, 45 (22.5%) died, and 155(77.5%) patients discharged home alive. The non-survivors were significantly older and had elevated markers of inflammation, coagulation, and acute organ damage on presentation. Age ≥ 65 years (odds ratio (OR), 3.78; 95% CI, 1.74-8.22; P = .001), lactate dehydrogenase level > 400 IU/L (OR, 9.1; 95% CI, 2.97-28.1; p < 0.001), C-reactive protein > 20 mg/dl (OR, 5.56; 95%CI, 1.84-16.8; p < 0.001), ferritin > 2000 ng/ml (OR, 5.42; 95%CI, 1.63-17.9; p = 0.006), creatinine kinase > 1000 iu/l (OR, 3.57; 95% CI, 1.23 10.3; p = 0.019), procalcitonin > 2.5 ng/ml (OR, 4.21; 95% CI, 1.47-12.0; p = 0.007), D-dimer level > 3.0 μg/ml (OR,10.9; 95% CI, 3.33-36.2; p = < 0.001), creatinine > 2 mg/dl (OR, 4.5; 95% CI, 1.29-15.8; P = 0.018) at admission were associated independently with increases risk of in-hospital mortality.
Conclusion:
Patients of advanced age that present with elevated biomarkers of inflammation, coagulation, and end-organ damage were at higher risk of mortality.
More Related Videos
05:16Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
14:43A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Related Concept Videos
Pneumonia III: Complications and Assessment
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Comparing the Survival Analysis of Two or More Groups
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Bias in Epidemiological Studies